The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: A prospective, randomized, double-blind clinical trial

Laryngoscope

Volumn 117, Issue 4, 2007, Pages 684-690

  Westerlaken, Boris O ^a   De Kleine, Emile ^a   Van Der Laan, Bernard ^a   Albers, Frans ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Idiopathic sudden sensorineural hearing loss (ISSHL); Prospective, randomized, double blind clinical trial; Sudden hearing loss

Indexed keywords

DEXAMETHASONE; PREDNISONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; EUPHORIA; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PERCEPTION DEAFNESS; PRESSURE SENSATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SPEECH AUDIOMETRY; SPEECH DISCRIMINATION; SUDDEN DEAFNESS; THERAPY EFFECT; TINNITUS; TREATMENT OUTCOME; VERTIGO;

ADULT; ANTI-INFLAMMATORY AGENTS; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; PULSE THERAPY, DRUG; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SPEECH DISCRIMINATION TESTS; SPEECH PERCEPTION; TINNITUS; VERTIGO;

EID: 34147140814     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/mlg.0b013e3180316d3b     Document Type: Article

References (15)

1. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463-480.
2. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989;10:242-247.
3. Wilson WR, Veltri RW, Laird N, Sprinkle PM. Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 1983;91:653-658.
4. Suckfull M; Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-1817. Erratum in: Lancet 2003;361:1916.
5. Harris JP, Ryan AF. Immunobiology of the inner ear. Am J Otolaryngol 1984;5:418-425.
6. Fitzgerald DC, Mark AS. Sudden hearing loss: frequency of abnormal findings on contrast-enhanced MR studies. AJNR Am J Neuroradiol 1998;19:1433-1436.
7. Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol 1973;76:75-97.
8. Liao BS, Byl FM, Adour KK. Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause. Otolaryngol Head Neck Surg 1992;106:226-229.
9. Berrocal JR, Ramirez-Camacho R. Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol 2002;111:989-997.
10. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980;106:772-776.
11. Garcia Berrocal JR, Ramirez-Camacho R. Immune response and immunopathology of the inner ear: an update. J Laryngol Otol 2000;114:101-107.
12. Roujeau JC. Pulse glucocorticoid therapy. The 'big shot' revisited. Arch Dermatol 1996;132:1499-1502.
13. Toth GG, Kloosterman C, Uges DR, Jonkman MF. Pharmacokinetics of high-dose oral and intravenous dexamethasone. Ther Drug Monit 1999;21:532-535.
14. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 2003;112:993-1000.
15. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-1208.